MEDICAL RESOURCES

Tepotinib MET kinase inhibitor

Status

• Tepotinib (also known as MSC2156119J) is an investigational small molecule inhibitor of the MET receptor tyrosine kinase

• Alterations in the MET signaling pathway are found in various cancer types and appear to correlate with aggressive tumor behavior and poor clinical prognosis

Action SVG
Action SVG
Action SVG
eMedI Chat
Close
After your vist, Please answer a few questions to help us improve?
Survey
Please click on icon to provide survey...